Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|February 2, 2024
UGT1A1 Testing in Breast Cancer: should it become routine practice in patients treated with antibody-drug conjugates?Rebecca Ibrahim, Rita Khoury, Tony Ibrahim, et al.Biomedicines|July 29, 2023
LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of ImmunotherapyRebecca Ibrahim, Khalil Saleh, Claude Chahine, et al.Translational Oncology|June 2, 2023
Overview of the role of liquid biopsy in cancer managementTarek Assi, Rita Khoury, Rebecca Ibrahim, et al.International Journal of Molecular Sciences|June 10, 2023
Mechanisms of Resistance to Antibody-Drug ConjugatesRita Khoury, Khalil Saleh, Nadine Khalife, et al.Journal of Personalized Medicine|July 27, 2024
The Evolving Role of Bispecific Antibodies in Diffuse Large B-Cell LymphomaKhalil Saleh, Rita Khoury, Nadine Khalife, et al.Cancer Drug Resistance (Alhambra, Calif.)|July 25, 2024
Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancerKhalil Saleh, Rita Khoury, Nadine Khalife, et al.Current Treatment Options in Oncology|February 7, 2024
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue SarcomasRita Khoury, Tarek Assi, Rebecca Ibrahim, et al.Biomedicines|January 8, 2025
Updates on Chimeric Antigen Receptor T-Cells in Large B-Cell LymphomaKhalil Saleh, Nadine Khalife, Ahmadreza Arbab, et al.Cancer Treatment Reviews|December 30, 2023
Desmoid-type fibromatosis: Current therapeutic strategies and future perspectivesRebecca Ibrahim, Tarek Assi, Rita Khoury, et al.Chinese Clinical Oncology|March 9, 2026
The evolution of bispecific antibodies in multiple myelomaRebecca Ibrahim, Nadine Khalife, Ahmadreza Arbab, et al.Pageof 2